Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective cohort study.
Paul
P
Welsh
Mike J L
MJ
Peters
Iain B
IB
McInnes
Willem F
WF
Lems
Paul T
PT
Lips
Gayle
G
McKellar
Susan
S
Knox
A
A
Michael Wallace
Ben A C
BA
Dijkmans
Michael T
MT
Nurmohamed
Naveed
N
Sattar
D000068879:Adalimumab; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012621:Seasons; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood; D014808:Vitamin D Deficiency / Q000209:etiology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D014807:Vitamin D; C104450:25-hydroxyvitamin D; D000068879:Adalimumab